nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—Methotrexate—urinary bladder cancer	0.335	1	CrCtD
Folic Acid—MTHFR—urinary bladder cancer	0.135	1	CbGaD
Folic Acid—GGH—Methotrexate—urinary bladder cancer	0.049	0.214	CbGbCtD
Folic Acid—Pemetrexed—Methotrexate—urinary bladder cancer	0.0442	0.2	CrCrCtD
Folic Acid—Leucovorin—Methotrexate—urinary bladder cancer	0.0442	0.2	CrCrCtD
Folic Acid—Tetrahydrofolic acid—Methotrexate—urinary bladder cancer	0.0442	0.2	CrCrCtD
Folic Acid—Pralatrexate—Methotrexate—urinary bladder cancer	0.0442	0.2	CrCrCtD
Folic Acid—Raltitrexed—Methotrexate—urinary bladder cancer	0.0442	0.2	CrCrCtD
Folic Acid—SLC46A1—Methotrexate—urinary bladder cancer	0.0281	0.123	CbGbCtD
Folic Acid—MTHFR—Fluorouracil—urinary bladder cancer	0.0267	0.116	CbGbCtD
Folic Acid—ABCC11—Methotrexate—urinary bladder cancer	0.0235	0.103	CbGbCtD
Folic Acid—MTHFR—Methotrexate—urinary bladder cancer	0.0147	0.0642	CbGbCtD
Folic Acid—ABCC3—Fluorouracil—urinary bladder cancer	0.0118	0.0514	CbGbCtD
Folic Acid—ABCC3—Cisplatin—urinary bladder cancer	0.01	0.0437	CbGbCtD
Folic Acid—ABCC3—Etoposide—urinary bladder cancer	0.00983	0.0429	CbGbCtD
Folic Acid—ABCC4—Fluorouracil—urinary bladder cancer	0.00899	0.0393	CbGbCtD
Folic Acid—ABCC3—Doxorubicin—urinary bladder cancer	0.0067	0.0293	CbGbCtD
Folic Acid—ABCC3—Methotrexate—urinary bladder cancer	0.00649	0.0284	CbGbCtD
Folic Acid—ABCC4—Methotrexate—urinary bladder cancer	0.00496	0.0217	CbGbCtD
Folic Acid—ABCG2—Fluorouracil—urinary bladder cancer	0.00484	0.0211	CbGbCtD
Folic Acid—ABCG2—Carboplatin—urinary bladder cancer	0.00481	0.021	CbGbCtD
Folic Acid—ABCG2—Cisplatin—urinary bladder cancer	0.00411	0.0179	CbGbCtD
Folic Acid—ABCG2—Etoposide—urinary bladder cancer	0.00404	0.0176	CbGbCtD
Folic Acid—CYP2E1—Etoposide—urinary bladder cancer	0.00288	0.0126	CbGbCtD
Folic Acid—ABCG2—Doxorubicin—urinary bladder cancer	0.00275	0.012	CbGbCtD
Folic Acid—ABCG2—Methotrexate—urinary bladder cancer	0.00267	0.0116	CbGbCtD
Folic Acid—SLC22A6—Methotrexate—urinary bladder cancer	0.00216	0.00943	CbGbCtD
Folic Acid—SLC25A32—prostate gland—urinary bladder cancer	0.0012	0.0521	CbGeAlD
Folic Acid—FOLR2—prostate gland—urinary bladder cancer	0.00119	0.0517	CbGeAlD
Folic Acid—SLC25A32—seminal vesicle—urinary bladder cancer	0.00102	0.0441	CbGeAlD
Folic Acid—FOLR2—seminal vesicle—urinary bladder cancer	0.00101	0.0437	CbGeAlD
Folic Acid—SLC46A1—prostate gland—urinary bladder cancer	0.000934	0.0404	CbGeAlD
Folic Acid—GGH—prostate gland—urinary bladder cancer	0.000919	0.0398	CbGeAlD
Folic Acid—SLC25A32—smooth muscle tissue—urinary bladder cancer	0.000851	0.0369	CbGeAlD
Folic Acid—SLC25A32—urethra—urinary bladder cancer	0.000805	0.0349	CbGeAlD
Folic Acid—FOLR2—urethra—urinary bladder cancer	0.000799	0.0346	CbGeAlD
Folic Acid—SLC46A1—seminal vesicle—urinary bladder cancer	0.00079	0.0342	CbGeAlD
Folic Acid—Pralatrexate—SLC19A1—urinary bladder cancer	0.000779	0.332	CrCbGaD
Folic Acid—GGH—seminal vesicle—urinary bladder cancer	0.000777	0.0336	CbGeAlD
Folic Acid—ABCC11—female reproductive system—urinary bladder cancer	0.000723	0.0313	CbGeAlD
Folic Acid—SLC25A32—female reproductive system—urinary bladder cancer	0.000656	0.0284	CbGeAlD
Folic Acid—FOLR2—female reproductive system—urinary bladder cancer	0.000651	0.0282	CbGeAlD
Folic Acid—GGH—smooth muscle tissue—urinary bladder cancer	0.00065	0.0282	CbGeAlD
Folic Acid—GGH—renal system—urinary bladder cancer	0.000626	0.0271	CbGeAlD
Folic Acid—GGH—urethra—urinary bladder cancer	0.000615	0.0266	CbGeAlD
Folic Acid—CYP2E1—urine—urinary bladder cancer	0.000611	0.0264	CbGeAlD
Folic Acid—SLC25A32—vagina—urinary bladder cancer	0.000594	0.0257	CbGeAlD
Folic Acid—FOLR2—vagina—urinary bladder cancer	0.000589	0.0255	CbGeAlD
Folic Acid—MTHFR—prostate gland—urinary bladder cancer	0.00058	0.0251	CbGeAlD
Folic Acid—Irritability—Valrubicin—urinary bladder cancer	0.000515	0.0398	CcSEcCtD
Folic Acid—GGH—female reproductive system—urinary bladder cancer	0.000501	0.0217	CbGeAlD
Folic Acid—GGH—vagina—urinary bladder cancer	0.000453	0.0196	CbGeAlD
Folic Acid—ABCC3—prostate gland—urinary bladder cancer	0.000434	0.0188	CbGeAlD
Folic Acid—SLC25A32—lymph node—urinary bladder cancer	0.000384	0.0166	CbGeAlD
Folic Acid—FOLR2—lymph node—urinary bladder cancer	0.000381	0.0165	CbGeAlD
Folic Acid—ABCC4—prostate gland—urinary bladder cancer	0.000359	0.0155	CbGeAlD
Folic Acid—Methotrexate—SLC19A1—urinary bladder cancer	0.000343	0.146	CrCbGaD
Folic Acid—Flatulence—Valrubicin—urinary bladder cancer	0.00032	0.0248	CcSEcCtD
Folic Acid—MTHFR—female reproductive system—urinary bladder cancer	0.000317	0.0137	CbGeAlD
Folic Acid—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.000302	0.0233	CcSEcCtD
Folic Acid—Raltitrexed—TYMS—urinary bladder cancer	0.000299	0.127	CrCbGaD
Folic Acid—SLC46A1—lymph node—urinary bladder cancer	0.000298	0.0129	CbGeAlD
Folic Acid—ABCC3—renal system—urinary bladder cancer	0.000296	0.0128	CbGeAlD
Folic Acid—GGH—lymph node—urinary bladder cancer	0.000293	0.0127	CbGeAlD
Folic Acid—Malaise—Valrubicin—urinary bladder cancer	0.000293	0.0227	CcSEcCtD
Folic Acid—Sensitisation—Epirubicin—urinary bladder cancer	0.00029	0.0224	CcSEcCtD
Folic Acid—Discomfort—Valrubicin—urinary bladder cancer	0.000273	0.0211	CcSEcCtD
Folic Acid—Sensitisation—Doxorubicin—urinary bladder cancer	0.000269	0.0208	CcSEcCtD
Folic Acid—ABCG2—prostate gland—urinary bladder cancer	0.000253	0.011	CbGeAlD
Folic Acid—ABCC4—renal system—urinary bladder cancer	0.000244	0.0106	CbGeAlD
Folic Acid—ABCC3—female reproductive system—urinary bladder cancer	0.000237	0.0103	CbGeAlD
Folic Acid—Pralatrexate—TYMS—urinary bladder cancer	0.000226	0.0963	CrCbGaD
Folic Acid—Leucovorin—TYMS—urinary bladder cancer	0.000226	0.0963	CrCbGaD
Folic Acid—Erythema—Mitomycin—urinary bladder cancer	0.000224	0.0173	CcSEcCtD
Folic Acid—CYP2E1—prostate gland—urinary bladder cancer	0.000219	0.00949	CbGeAlD
Folic Acid—Feeling abnormal—Valrubicin—urinary bladder cancer	0.000219	0.0169	CcSEcCtD
Folic Acid—ABCG2—seminal vesicle—urinary bladder cancer	0.000214	0.00927	CbGeAlD
Folic Acid—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.000208	0.0161	CcSEcCtD
Folic Acid—Malaise—Mitomycin—urinary bladder cancer	0.000202	0.0156	CcSEcCtD
Folic Acid—ABCC4—female reproductive system—urinary bladder cancer	0.000196	0.00848	CbGeAlD
Folic Acid—Discomfort—Mitomycin—urinary bladder cancer	0.000188	0.0146	CcSEcCtD
Folic Acid—Pruritus—Valrubicin—urinary bladder cancer	0.000188	0.0145	CcSEcCtD
Folic Acid—CYP2E1—seminal vesicle—urinary bladder cancer	0.000185	0.00803	CbGeAlD
Folic Acid—MTHFR—lymph node—urinary bladder cancer	0.000185	0.00803	CbGeAlD
Folic Acid—Confusional state—Mitomycin—urinary bladder cancer	0.000184	0.0142	CcSEcCtD
Folic Acid—Pemetrexed—TYMS—urinary bladder cancer	0.000181	0.077	CrCbGaD
Folic Acid—Anorexia—Mitomycin—urinary bladder cancer	0.000174	0.0135	CcSEcCtD
Folic Acid—ABCG2—urethra—urinary bladder cancer	0.000169	0.00734	CbGeAlD
Folic Acid—Rash—Valrubicin—urinary bladder cancer	0.000167	0.0129	CcSEcCtD
Folic Acid—Dermatitis—Valrubicin—urinary bladder cancer	0.000167	0.0129	CcSEcCtD
Folic Acid—Dyspnoea—Mitomycin—urinary bladder cancer	0.000163	0.0126	CcSEcCtD
Folic Acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.000159	0.0123	CcSEcCtD
Folic Acid—Nausea—Valrubicin—urinary bladder cancer	0.000158	0.0122	CcSEcCtD
Folic Acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000151	0.0116	CcSEcCtD
Folic Acid—CYP2E1—renal system—urinary bladder cancer	0.000149	0.00647	CbGeAlD
Folic Acid—Irritability—Fluorouracil—urinary bladder cancer	0.000148	0.0114	CcSEcCtD
Folic Acid—CYP2E1—urethra—urinary bladder cancer	0.000147	0.00636	CbGeAlD
Folic Acid—Irritability—Cisplatin—urinary bladder cancer	0.00014	0.0108	CcSEcCtD
Folic Acid—ABCC3—lymph node—urinary bladder cancer	0.000139	0.00601	CbGeAlD
Folic Acid—Bronchospasm—Gemcitabine—urinary bladder cancer	0.000134	0.0103	CcSEcCtD
Folic Acid—ABCG2—vagina—urinary bladder cancer	0.000125	0.00541	CbGeAlD
Folic Acid—CYP2E1—female reproductive system—urinary bladder cancer	0.00012	0.00518	CbGeAlD
Folic Acid—Tetrahydrofolic acid—MTHFR—urinary bladder cancer	0.000116	0.0493	CrCbGaD
Folic Acid—Rash—Mitomycin—urinary bladder cancer	0.000115	0.00891	CcSEcCtD
Folic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.000115	0.0089	CcSEcCtD
Folic Acid—ABCC4—lymph node—urinary bladder cancer	0.000115	0.00496	CbGeAlD
Folic Acid—Bronchospasm—Etoposide—urinary bladder cancer	0.000114	0.00883	CcSEcCtD
Folic Acid—Erythema—Thiotepa—urinary bladder cancer	0.000113	0.0087	CcSEcCtD
Folic Acid—Nausea—Mitomycin—urinary bladder cancer	0.000109	0.00839	CcSEcCtD
Folic Acid—Agitation—Thiotepa—urinary bladder cancer	0.000104	0.008	CcSEcCtD
Folic Acid—Methotrexate—TYMS—urinary bladder cancer	9.98e-05	0.0424	CrCbGaD
Folic Acid—Convulsion—Thiotepa—urinary bladder cancer	9.76e-05	0.00754	CcSEcCtD
Folic Acid—Erythema—Gemcitabine—urinary bladder cancer	9.48e-05	0.00732	CcSEcCtD
Folic Acid—Erythema—Fluorouracil—urinary bladder cancer	9.32e-05	0.0072	CcSEcCtD
Folic Acid—Confusional state—Thiotepa—urinary bladder cancer	9.27e-05	0.00716	CcSEcCtD
Folic Acid—Erythema—Cisplatin—urinary bladder cancer	8.83e-05	0.00682	CcSEcCtD
Folic Acid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	8.79e-05	0.00679	CcSEcCtD
Folic Acid—Anorexia—Thiotepa—urinary bladder cancer	8.76e-05	0.00677	CcSEcCtD
Folic Acid—Flatulence—Cisplatin—urinary bladder cancer	8.7e-05	0.00672	CcSEcCtD
Folic Acid—Malaise—Gemcitabine—urinary bladder cancer	8.54e-05	0.0066	CcSEcCtD
Folic Acid—Ill-defined disorder—Cisplatin—urinary bladder cancer	8.19e-05	0.00633	CcSEcCtD
Folic Acid—Dyspepsia—Thiotepa—urinary bladder cancer	8.09e-05	0.00625	CcSEcCtD
Folic Acid—ABCG2—lymph node—urinary bladder cancer	8.08e-05	0.0035	CbGeAlD
Folic Acid—Convulsion—Fluorouracil—urinary bladder cancer	8.07e-05	0.00624	CcSEcCtD
Folic Acid—Decreased appetite—Thiotepa—urinary bladder cancer	7.99e-05	0.00618	CcSEcCtD
Folic Acid—Discomfort—Gemcitabine—urinary bladder cancer	7.97e-05	0.00616	CcSEcCtD
Folic Acid—Malaise—Cisplatin—urinary bladder cancer	7.96e-05	0.00615	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	7.94e-05	0.00613	CcSEcCtD
Folic Acid—Methotrexate—MTHFR—urinary bladder cancer	7.93e-05	0.0338	CrCbGaD
Folic Acid—Dysgeusia—Etoposide—urinary bladder cancer	7.92e-05	0.00612	CcSEcCtD
Folic Acid—Discomfort—Fluorouracil—urinary bladder cancer	7.84e-05	0.00606	CcSEcCtD
Folic Acid—Anaphylactic shock—Gemcitabine—urinary bladder cancer	7.73e-05	0.00598	CcSEcCtD
Folic Acid—Irritability—Methotrexate—urinary bladder cancer	7.68e-05	0.00594	CcSEcCtD
Folic Acid—Confusional state—Fluorouracil—urinary bladder cancer	7.67e-05	0.00592	CcSEcCtD
Folic Acid—Convulsion—Cisplatin—urinary bladder cancer	7.65e-05	0.00591	CcSEcCtD
Folic Acid—Anaphylactic shock—Fluorouracil—urinary bladder cancer	7.6e-05	0.00588	CcSEcCtD
Folic Acid—Feeling abnormal—Thiotepa—urinary bladder cancer	7.58e-05	0.00585	CcSEcCtD
Folic Acid—Ill-defined disorder—Etoposide—urinary bladder cancer	7.51e-05	0.0058	CcSEcCtD
Folic Acid—Discomfort—Cisplatin—urinary bladder cancer	7.43e-05	0.00574	CcSEcCtD
Folic Acid—Anorexia—Gemcitabine—urinary bladder cancer	7.37e-05	0.0057	CcSEcCtD
Folic Acid—Malaise—Etoposide—urinary bladder cancer	7.3e-05	0.00564	CcSEcCtD
Folic Acid—Anorexia—Fluorouracil—urinary bladder cancer	7.25e-05	0.0056	CcSEcCtD
Folic Acid—Anaphylactic shock—Cisplatin—urinary bladder cancer	7.21e-05	0.00557	CcSEcCtD
Folic Acid—Convulsion—Etoposide—urinary bladder cancer	7.01e-05	0.00542	CcSEcCtD
Folic Acid—Dyspnoea—Gemcitabine—urinary bladder cancer	6.89e-05	0.00533	CcSEcCtD
Folic Acid—Anorexia—Cisplatin—urinary bladder cancer	6.87e-05	0.00531	CcSEcCtD
Folic Acid—Discomfort—Etoposide—urinary bladder cancer	6.81e-05	0.00526	CcSEcCtD
Folic Acid—Dyspnoea—Fluorouracil—urinary bladder cancer	6.78e-05	0.00524	CcSEcCtD
Folic Acid—Decreased appetite—Gemcitabine—urinary bladder cancer	6.72e-05	0.00519	CcSEcCtD
Folic Acid—Dyspepsia—Fluorouracil—urinary bladder cancer	6.69e-05	0.00517	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6.68e-05	0.00516	CcSEcCtD
Folic Acid—Confusional state—Etoposide—urinary bladder cancer	6.66e-05	0.00515	CcSEcCtD
Folic Acid—Decreased appetite—Fluorouracil—urinary bladder cancer	6.61e-05	0.00511	CcSEcCtD
Folic Acid—Anaphylactic shock—Etoposide—urinary bladder cancer	6.6e-05	0.0051	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	6.56e-05	0.00507	CcSEcCtD
Folic Acid—Abdominal distension—Epirubicin—urinary bladder cancer	6.55e-05	0.00506	CcSEcCtD
Folic Acid—Pruritus—Thiotepa—urinary bladder cancer	6.5e-05	0.00503	CcSEcCtD
Folic Acid—Dyspnoea—Cisplatin—urinary bladder cancer	6.43e-05	0.00497	CcSEcCtD
Folic Acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	6.37e-05	0.00492	CcSEcCtD
Folic Acid—Anorexia—Etoposide—urinary bladder cancer	6.29e-05	0.00486	CcSEcCtD
Folic Acid—Decreased appetite—Cisplatin—urinary bladder cancer	6.27e-05	0.00484	CcSEcCtD
Folic Acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	6.27e-05	0.00484	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	6.22e-05	0.00481	CcSEcCtD
Folic Acid—Depression—Methotrexate—urinary bladder cancer	6.18e-05	0.00478	CcSEcCtD
Folic Acid—Abdominal distension—Doxorubicin—urinary bladder cancer	6.06e-05	0.00469	CcSEcCtD
Folic Acid—Feeling abnormal—Cisplatin—urinary bladder cancer	5.94e-05	0.00459	CcSEcCtD
Folic Acid—Dyspnoea—Etoposide—urinary bladder cancer	5.89e-05	0.00455	CcSEcCtD
Folic Acid—Rash—Thiotepa—urinary bladder cancer	5.8e-05	0.00448	CcSEcCtD
Folic Acid—Dermatitis—Thiotepa—urinary bladder cancer	5.79e-05	0.00447	CcSEcCtD
Folic Acid—Decreased appetite—Etoposide—urinary bladder cancer	5.74e-05	0.00444	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.7e-05	0.00441	CcSEcCtD
Folic Acid—Pruritus—Gemcitabine—urinary bladder cancer	5.47e-05	0.00423	CcSEcCtD
Folic Acid—Nausea—Thiotepa—urinary bladder cancer	5.46e-05	0.00422	CcSEcCtD
Folic Acid—Feeling abnormal—Etoposide—urinary bladder cancer	5.44e-05	0.0042	CcSEcCtD
Folic Acid—Pruritus—Fluorouracil—urinary bladder cancer	5.38e-05	0.00416	CcSEcCtD
Folic Acid—Rash—Gemcitabine—urinary bladder cancer	4.88e-05	0.00377	CcSEcCtD
Folic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	4.87e-05	0.00376	CcSEcCtD
Folic Acid—Erythema—Methotrexate—urinary bladder cancer	4.85e-05	0.00375	CcSEcCtD
Folic Acid—Rash—Fluorouracil—urinary bladder cancer	4.79e-05	0.0037	CcSEcCtD
Folic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	4.79e-05	0.0037	CcSEcCtD
Folic Acid—Dysgeusia—Methotrexate—urinary bladder cancer	4.75e-05	0.00367	CcSEcCtD
Folic Acid—Pruritus—Etoposide—urinary bladder cancer	4.67e-05	0.00361	CcSEcCtD
Folic Acid—Nausea—Gemcitabine—urinary bladder cancer	4.59e-05	0.00355	CcSEcCtD
Folic Acid—Rash—Cisplatin—urinary bladder cancer	4.54e-05	0.00351	CcSEcCtD
Folic Acid—Dermatitis—Cisplatin—urinary bladder cancer	4.54e-05	0.00351	CcSEcCtD
Folic Acid—Erythema—Epirubicin—urinary bladder cancer	4.54e-05	0.0035	CcSEcCtD
Folic Acid—Nausea—Fluorouracil—urinary bladder cancer	4.52e-05	0.00349	CcSEcCtD
Folic Acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.5e-05	0.00347	CcSEcCtD
Folic Acid—Flatulence—Epirubicin—urinary bladder cancer	4.47e-05	0.00345	CcSEcCtD
Folic Acid—Dysgeusia—Epirubicin—urinary bladder cancer	4.44e-05	0.00343	CcSEcCtD
Folic Acid—Malaise—Methotrexate—urinary bladder cancer	4.37e-05	0.00338	CcSEcCtD
Folic Acid—Nausea—Cisplatin—urinary bladder cancer	4.28e-05	0.00331	CcSEcCtD
Folic Acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.21e-05	0.00325	CcSEcCtD
Folic Acid—Convulsion—Methotrexate—urinary bladder cancer	4.2e-05	0.00324	CcSEcCtD
Folic Acid—Erythema—Doxorubicin—urinary bladder cancer	4.2e-05	0.00324	CcSEcCtD
Folic Acid—Agitation—Epirubicin—urinary bladder cancer	4.17e-05	0.00322	CcSEcCtD
Folic Acid—Rash—Etoposide—urinary bladder cancer	4.16e-05	0.00322	CcSEcCtD
Folic Acid—Dermatitis—Etoposide—urinary bladder cancer	4.16e-05	0.00321	CcSEcCtD
Folic Acid—Flatulence—Doxorubicin—urinary bladder cancer	4.14e-05	0.0032	CcSEcCtD
Folic Acid—Dysgeusia—Doxorubicin—urinary bladder cancer	4.11e-05	0.00318	CcSEcCtD
Folic Acid—Malaise—Epirubicin—urinary bladder cancer	4.09e-05	0.00316	CcSEcCtD
Folic Acid—Discomfort—Methotrexate—urinary bladder cancer	4.08e-05	0.00315	CcSEcCtD
Folic Acid—Confusional state—Methotrexate—urinary bladder cancer	3.99e-05	0.00308	CcSEcCtD
Folic Acid—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.96e-05	0.00306	CcSEcCtD
Folic Acid—Convulsion—Epirubicin—urinary bladder cancer	3.93e-05	0.00304	CcSEcCtD
Folic Acid—Nausea—Etoposide—urinary bladder cancer	3.92e-05	0.00303	CcSEcCtD
Folic Acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.89e-05	0.00301	CcSEcCtD
Folic Acid—Agitation—Doxorubicin—urinary bladder cancer	3.86e-05	0.00298	CcSEcCtD
Folic Acid—Discomfort—Epirubicin—urinary bladder cancer	3.82e-05	0.00295	CcSEcCtD
Folic Acid—Malaise—Doxorubicin—urinary bladder cancer	3.78e-05	0.00292	CcSEcCtD
Folic Acid—Anorexia—Methotrexate—urinary bladder cancer	3.77e-05	0.00291	CcSEcCtD
Folic Acid—Confusional state—Epirubicin—urinary bladder cancer	3.73e-05	0.00288	CcSEcCtD
Folic Acid—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.7e-05	0.00286	CcSEcCtD
Folic Acid—Convulsion—Doxorubicin—urinary bladder cancer	3.64e-05	0.00281	CcSEcCtD
Folic Acid—Discomfort—Doxorubicin—urinary bladder cancer	3.53e-05	0.00273	CcSEcCtD
Folic Acid—Anorexia—Epirubicin—urinary bladder cancer	3.53e-05	0.00273	CcSEcCtD
Folic Acid—Dyspnoea—Methotrexate—urinary bladder cancer	3.53e-05	0.00272	CcSEcCtD
Folic Acid—Dyspepsia—Methotrexate—urinary bladder cancer	3.48e-05	0.00269	CcSEcCtD
Folic Acid—Confusional state—Doxorubicin—urinary bladder cancer	3.45e-05	0.00267	CcSEcCtD
Folic Acid—Decreased appetite—Methotrexate—urinary bladder cancer	3.44e-05	0.00266	CcSEcCtD
Folic Acid—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.42e-05	0.00265	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.41e-05	0.00264	CcSEcCtD
Folic Acid—Dyspnoea—Epirubicin—urinary bladder cancer	3.3e-05	0.00255	CcSEcCtD
Folic Acid—Anorexia—Doxorubicin—urinary bladder cancer	3.26e-05	0.00252	CcSEcCtD
Folic Acid—Feeling abnormal—Methotrexate—urinary bladder cancer	3.26e-05	0.00252	CcSEcCtD
Folic Acid—Dyspepsia—Epirubicin—urinary bladder cancer	3.26e-05	0.00252	CcSEcCtD
Folic Acid—Decreased appetite—Epirubicin—urinary bladder cancer	3.22e-05	0.00249	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.2e-05	0.00247	CcSEcCtD
Folic Acid—Dyspnoea—Doxorubicin—urinary bladder cancer	3.05e-05	0.00236	CcSEcCtD
Folic Acid—Feeling abnormal—Epirubicin—urinary bladder cancer	3.05e-05	0.00236	CcSEcCtD
Folic Acid—Dyspepsia—Doxorubicin—urinary bladder cancer	3.01e-05	0.00233	CcSEcCtD
Folic Acid—Decreased appetite—Doxorubicin—urinary bladder cancer	2.98e-05	0.0023	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.96e-05	0.00228	CcSEcCtD
Folic Acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.82e-05	0.00218	CcSEcCtD
Folic Acid—Pruritus—Methotrexate—urinary bladder cancer	2.8e-05	0.00216	CcSEcCtD
Folic Acid—SLC25A32—Disease—ERCC2—urinary bladder cancer	2.63e-05	0.000635	CbGpPWpGaD
Folic Acid—Pruritus—Epirubicin—urinary bladder cancer	2.62e-05	0.00202	CcSEcCtD
Folic Acid—ABCC4—NRF2 pathway—GSTM1—urinary bladder cancer	2.61e-05	0.00063	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—GSTP1—urinary bladder cancer	2.55e-05	0.000615	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTZ1—urinary bladder cancer	2.53e-05	0.000611	CbGpPWpGaD
Folic Acid—Rash—Methotrexate—urinary bladder cancer	2.49e-05	0.00193	CcSEcCtD
Folic Acid—Dermatitis—Methotrexate—urinary bladder cancer	2.49e-05	0.00193	CcSEcCtD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	2.49e-05	0.000601	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—MTHFR—urinary bladder cancer	2.47e-05	0.000597	CbGpPWpGaD
Folic Acid—MTHFR—Selenium Micronutrient Network—TNF—urinary bladder cancer	2.47e-05	0.000596	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—TERT—urinary bladder cancer	2.46e-05	0.000595	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	2.44e-05	0.000589	CbGpPWpGaD
Folic Acid—Pruritus—Doxorubicin—urinary bladder cancer	2.42e-05	0.00187	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—TYMP—urinary bladder cancer	2.41e-05	0.000581	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	2.41e-05	0.000581	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTO2—urinary bladder cancer	2.4e-05	0.000579	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NAT1—urinary bladder cancer	2.4e-05	0.000579	CbGpPWpGaD
Folic Acid—ABCC11—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.39e-05	0.000576	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.37e-05	0.000574	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—TYMS—urinary bladder cancer	2.37e-05	0.000572	CbGpPWpGaD
Folic Acid—Nausea—Methotrexate—urinary bladder cancer	2.35e-05	0.00182	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—GSTM1—urinary bladder cancer	2.34e-05	0.000566	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—NCOR1—urinary bladder cancer	2.34e-05	0.000566	CbGpPWpGaD
Folic Acid—Rash—Epirubicin—urinary bladder cancer	2.33e-05	0.0018	CcSEcCtD
Folic Acid—Dermatitis—Epirubicin—urinary bladder cancer	2.33e-05	0.0018	CcSEcCtD
Folic Acid—ABCG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.26e-05	0.000547	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—FGFR3—urinary bladder cancer	2.26e-05	0.000546	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—GPX1—urinary bladder cancer	2.24e-05	0.000542	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.23e-05	0.000539	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SLC19A1—urinary bladder cancer	2.23e-05	0.000538	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—ERCC2—urinary bladder cancer	2.2e-05	0.000532	CbGpPWpGaD
Folic Acid—Nausea—Epirubicin—urinary bladder cancer	2.2e-05	0.0017	CcSEcCtD
Folic Acid—MTHFR—Metabolism—UGT2B7—urinary bladder cancer	2.19e-05	0.00053	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—NAT2—urinary bladder cancer	2.18e-05	0.000526	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PRSS3—urinary bladder cancer	2.17e-05	0.000524	CbGpPWpGaD
Folic Acid—Rash—Doxorubicin—urinary bladder cancer	2.16e-05	0.00167	CcSEcCtD
Folic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	2.16e-05	0.00167	CcSEcCtD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TP53—urinary bladder cancer	2.11e-05	0.00051	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—ENO2—urinary bladder cancer	2.08e-05	0.000502	CbGpPWpGaD
Folic Acid—MTHFR—Disease—HDAC4—urinary bladder cancer	2.07e-05	0.0005	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—MTHFR—urinary bladder cancer	2.07e-05	0.0005	CbGpPWpGaD
Folic Acid—Nausea—Doxorubicin—urinary bladder cancer	2.03e-05	0.00157	CcSEcCtD
Folic Acid—MTHFR—Metabolism—CYP4B1—urinary bladder cancer	1.97e-05	0.000477	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—RBX1—urinary bladder cancer	1.97e-05	0.000476	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	1.95e-05	0.000471	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.94e-05	0.000469	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.94e-05	0.000468	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—CREBBP—urinary bladder cancer	1.92e-05	0.000465	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	1.89e-05	0.000457	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—RRM2—urinary bladder cancer	1.88e-05	0.000454	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.87e-05	0.000452	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—SLC19A1—urinary bladder cancer	1.86e-05	0.00045	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.82e-05	0.00044	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PRSS3—urinary bladder cancer	1.82e-05	0.000439	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—JAG1—urinary bladder cancer	1.76e-05	0.000426	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—RHOA—urinary bladder cancer	1.74e-05	0.000421	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—ENO2—urinary bladder cancer	1.74e-05	0.00042	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—HPGDS—urinary bladder cancer	1.74e-05	0.00042	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	1.69e-05	0.000409	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GSTT1—urinary bladder cancer	1.69e-05	0.000408	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PPARG—urinary bladder cancer	1.68e-05	0.000405	CbGpPWpGaD
Folic Acid—MTHFR—Disease—LIG1—urinary bladder cancer	1.64e-05	0.000397	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.64e-05	0.000395	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTZ1—urinary bladder cancer	1.62e-05	0.000392	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—CREBBP—urinary bladder cancer	1.61e-05	0.000389	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—ERBB2—urinary bladder cancer	1.61e-05	0.000389	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.58e-05	0.000383	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.58e-05	0.000382	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—PTGS2—urinary bladder cancer	1.58e-05	0.000381	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTO2—urinary bladder cancer	1.54e-05	0.000372	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NAT1—urinary bladder cancer	1.54e-05	0.000372	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.51e-05	0.000365	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—TYMP—urinary bladder cancer	1.45e-05	0.000351	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—UGT2B7—urinary bladder cancer	1.41e-05	0.00034	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—NQO1—urinary bladder cancer	1.4e-05	0.000339	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—CDKN1A—urinary bladder cancer	1.38e-05	0.000333	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—PTEN—urinary bladder cancer	1.37e-05	0.000332	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.33e-05	0.000322	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	0.000319	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NAT2—urinary bladder cancer	1.31e-05	0.000317	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	1.31e-05	0.000317	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—EP300—urinary bladder cancer	1.31e-05	0.000317	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.31e-05	0.000316	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.29e-05	0.000312	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—NCOR1—urinary bladder cancer	1.28e-05	0.00031	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—SRC—urinary bladder cancer	1.27e-05	0.000308	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	1.27e-05	0.000308	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP4B1—urinary bladder cancer	1.27e-05	0.000306	CbGpPWpGaD
Folic Acid—MTHFR—Disease—ENO2—urinary bladder cancer	1.25e-05	0.000303	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.23e-05	0.000297	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—ERCC2—urinary bladder cancer	1.21e-05	0.000292	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	1.21e-05	0.000291	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—SLC19A1—urinary bladder cancer	1.2e-05	0.000289	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.19e-05	0.000287	CbGpPWpGaD
Folic Acid—MTHFR—Disease—RBX1—urinary bladder cancer	1.19e-05	0.000287	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GSTP1—urinary bladder cancer	1.17e-05	0.000283	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	1.17e-05	0.000282	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PRSS3—urinary bladder cancer	1.17e-05	0.000282	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PTEN—urinary bladder cancer	1.15e-05	0.000278	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—MYC—urinary bladder cancer	1.14e-05	0.000276	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	1.14e-05	0.000274	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MTHFR—urinary bladder cancer	1.13e-05	0.000274	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—RRM2—urinary bladder cancer	1.13e-05	0.000274	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—TERT—urinary bladder cancer	1.13e-05	0.000273	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTZ1—urinary bladder cancer	1.12e-05	0.00027	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—EGFR—urinary bladder cancer	1.12e-05	0.00027	CbGpPWpGaD
Folic Acid—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	1.12e-05	0.000269	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—EP300—urinary bladder cancer	1.1e-05	0.000265	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—TYMS—urinary bladder cancer	1.09e-05	0.000263	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	0.00026	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	0.00026	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.07e-05	0.000259	CbGpPWpGaD
Folic Acid—MTHFR—Disease—JAG1—urinary bladder cancer	1.06e-05	0.000257	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTO2—urinary bladder cancer	1.06e-05	0.000256	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NAT1—urinary bladder cancer	1.06e-05	0.000256	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—KRAS—urinary bladder cancer	1.06e-05	0.000255	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—HPGDS—urinary bladder cancer	1.05e-05	0.000254	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ENO2—urinary bladder cancer	1.05e-05	0.000254	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—FGFR3—urinary bladder cancer	1.04e-05	0.000251	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GPX1—urinary bladder cancer	1.03e-05	0.000249	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTT1—urinary bladder cancer	1.02e-05	0.000246	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—ERCC2—urinary bladder cancer	1.01e-05	0.000244	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	9.79e-06	0.000236	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—UGT2B7—urinary bladder cancer	9.7e-06	0.000234	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—MTHFR—urinary bladder cancer	9.5e-06	0.000229	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.35e-06	0.000226	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—TYMP—urinary bladder cancer	9.32e-06	0.000225	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.02e-06	0.000218	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—HRAS—urinary bladder cancer	8.97e-06	0.000217	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.95e-06	0.000216	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—CREBBP—urinary bladder cancer	8.84e-06	0.000213	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP4B1—urinary bladder cancer	8.73e-06	0.000211	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	8.54e-06	0.000206	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NQO1—urinary bladder cancer	8.46e-06	0.000204	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NAT2—urinary bladder cancer	8.43e-06	0.000204	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—SLC19A1—urinary bladder cancer	8.25e-06	0.000199	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—PLAU—urinary bladder cancer	8.06e-06	0.000195	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PRSS3—urinary bladder cancer	8.04e-06	0.000194	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	8.03e-06	0.000194	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—RHOA—urinary bladder cancer	7.99e-06	0.000193	CbGpPWpGaD
Folic Acid—MTHFR—Disease—NCOR1—urinary bladder cancer	7.75e-06	0.000187	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PPARG—urinary bladder cancer	7.7e-06	0.000186	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	7.62e-06	0.000184	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NAT1—urinary bladder cancer	7.62e-06	0.000184	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—CREBBP—urinary bladder cancer	7.4e-06	0.000179	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—ERBB2—urinary bladder cancer	7.4e-06	0.000179	CbGpPWpGaD
Folic Acid—MTHFR—Disease—ERCC2—urinary bladder cancer	7.28e-06	0.000176	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—RRM2—urinary bladder cancer	7.28e-06	0.000176	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PTGS2—urinary bladder cancer	7.24e-06	0.000175	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTP1—urinary bladder cancer	7.06e-06	0.00017	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	6.97e-06	0.000168	CbGpPWpGaD
Folic Acid—MTHFR—Disease—TERT—urinary bladder cancer	6.83e-06	0.000165	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ENO2—urinary bladder cancer	6.74e-06	0.000163	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—HPGDS—urinary bladder cancer	6.74e-06	0.000163	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.7e-06	0.000162	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	6.65e-06	0.000161	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IGF1—urinary bladder cancer	6.56e-06	0.000159	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—TYMS—urinary bladder cancer	6.56e-06	0.000159	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTT1—urinary bladder cancer	6.54e-06	0.000158	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTM1—urinary bladder cancer	6.49e-06	0.000157	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NCOR1—urinary bladder cancer	6.49e-06	0.000157	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.44e-06	0.000155	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—TYMP—urinary bladder cancer	6.43e-06	0.000155	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—CDKN1A—urinary bladder cancer	6.33e-06	0.000153	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PTEN—urinary bladder cancer	6.31e-06	0.000152	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	6.27e-06	0.000151	CbGpPWpGaD
Folic Acid—MTHFR—Disease—FGFR3—urinary bladder cancer	6.26e-06	0.000151	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GPX1—urinary bladder cancer	6.21e-06	0.00015	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.12e-06	0.000148	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ERCC2—urinary bladder cancer	6.1e-06	0.000147	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PTGS2—urinary bladder cancer	6.06e-06	0.000146	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EP300—urinary bladder cancer	6.02e-06	0.000145	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—RHOA—urinary bladder cancer	6.01e-06	0.000145	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	5.92e-06	0.000143	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—SRC—urinary bladder cancer	5.85e-06	0.000141	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NAT2—urinary bladder cancer	5.81e-06	0.00014	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	5.77e-06	0.000139	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.75e-06	0.000139	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NQO1—urinary bladder cancer	5.43e-06	0.000131	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CREBBP—urinary bladder cancer	5.33e-06	0.000129	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PTEN—urinary bladder cancer	5.29e-06	0.000128	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.27e-06	0.000127	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MYC—urinary bladder cancer	5.24e-06	0.000127	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EGFR—urinary bladder cancer	5.13e-06	0.000124	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IL2—urinary bladder cancer	5.04e-06	0.000122	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—EP300—urinary bladder cancer	5.04e-06	0.000122	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—RRM2—urinary bladder cancer	5.02e-06	0.000121	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.01e-06	0.000121	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—KRAS—urinary bladder cancer	4.85e-06	0.000117	CbGpPWpGaD
Folic Acid—MTHFR—Disease—RHOA—urinary bladder cancer	4.82e-06	0.000117	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PPARG—urinary bladder cancer	4.65e-06	0.000112	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—HPGDS—urinary bladder cancer	4.65e-06	0.000112	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ENO2—urinary bladder cancer	4.65e-06	0.000112	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.61e-06	0.000111	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.6e-06	0.000111	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTP1—urinary bladder cancer	4.53e-06	0.000109	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—EP300—urinary bladder cancer	4.53e-06	0.000109	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTT1—urinary bladder cancer	4.51e-06	0.000109	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CREBBP—urinary bladder cancer	4.47e-06	0.000108	CbGpPWpGaD
Folic Acid—MTHFR—Disease—ERBB2—urinary bladder cancer	4.47e-06	0.000108	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—SRC—urinary bladder cancer	4.4e-06	0.000106	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.38e-06	0.000106	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTGS2—urinary bladder cancer	4.37e-06	0.000105	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.22e-06	0.000102	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—TYMS—urinary bladder cancer	4.21e-06	0.000102	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NAT2—urinary bladder cancer	4.17e-06	0.000101	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NCOR1—urinary bladder cancer	4.16e-06	0.000101	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTM1—urinary bladder cancer	4.16e-06	0.000101	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—HRAS—urinary bladder cancer	4.12e-06	9.95e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GPX1—urinary bladder cancer	3.99e-06	9.63e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ERCC2—urinary bladder cancer	3.91e-06	9.45e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CDKN1A—urinary bladder cancer	3.82e-06	9.22e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTEN—urinary bladder cancer	3.81e-06	9.2e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NQO1—urinary bladder cancer	3.75e-06	9.05e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—MTHFR—urinary bladder cancer	3.68e-06	8.89e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTGS2—urinary bladder cancer	3.66e-06	8.83e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—KRAS—urinary bladder cancer	3.64e-06	8.8e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EP300—urinary bladder cancer	3.63e-06	8.77e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.6e-06	8.7e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SRC—urinary bladder cancer	3.53e-06	8.53e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ENO2—urinary bladder cancer	3.34e-06	8.06e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	3.34e-06	8.06e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—urinary bladder cancer	3.24e-06	7.82e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	3.24e-06	7.81e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTEN—urinary bladder cancer	3.19e-06	7.7e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MYC—urinary bladder cancer	3.16e-06	7.64e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTP1—urinary bladder cancer	3.12e-06	7.54e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—HRAS—urinary bladder cancer	3.1e-06	7.48e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGFR—urinary bladder cancer	3.1e-06	7.48e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—EP300—urinary bladder cancer	3.04e-06	7.35e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PPARG—urinary bladder cancer	2.98e-06	7.21e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—KRAS—urinary bladder cancer	2.92e-06	7.06e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—TYMS—urinary bladder cancer	2.9e-06	7.01e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTM1—urinary bladder cancer	2.87e-06	6.93e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NCOR1—urinary bladder cancer	2.87e-06	6.93e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CREBBP—urinary bladder cancer	2.87e-06	6.92e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GPX1—urinary bladder cancer	2.75e-06	6.64e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ERCC2—urinary bladder cancer	2.7e-06	6.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.69e-06	6.49e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—MTHFR—urinary bladder cancer	2.54e-06	6.13e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—HRAS—urinary bladder cancer	2.49e-06	6e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTGS2—urinary bladder cancer	2.35e-06	5.67e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.24e-06	5.42e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.08e-06	5.04e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.06e-06	4.98e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.06e-06	4.98e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PPARG—urinary bladder cancer	2.06e-06	4.97e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTEN—urinary bladder cancer	2.05e-06	4.94e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.98e-06	4.77e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.97e-06	4.77e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—EP300—urinary bladder cancer	1.95e-06	4.71e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.94e-06	4.68e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.82e-06	4.4e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.62e-06	3.91e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.48e-06	3.57e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.42e-06	3.43e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.41e-06	3.41e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—EP300—urinary bladder cancer	1.35e-06	3.25e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.16e-06	2.81e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—EP300—urinary bladder cancer	9.66e-07	2.33e-05	CbGpPWpGaD
